Novomics Co Ltd
283100
Company Profile
Business description
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.
Contact
171 Dangsan-ro
304, 305, 306, 306-1, Yeongdeungpo-gu
Seoul
KORT: +82 220683700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
27
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,744.30 | 169.60 | -2.14% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,913.25 | 233.77 | 3.04% |
| HKSE | 20,681.78 | 417.29 | 2.06% |
| NASDAQ | 16,421.05 | 703.92 | -4.11% |
| Nikkei 225 | 32,756.78 | 1,852.22 | -5.35% |
| NZX 50 Index | 12,036.27 | 165.16 | -1.35% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,539.10 | 170.50 | -2.21% |
| SSE Composite Index | 3,223.64 | 36.83 | 1.16% |